2019 Full Year Results Investor Presentation
Filed with ASX · · 29 pages · English
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26
The information provided is general in nature and is in summary form only. It is not complete and should be read in conjunction with the company’s audited Financial Statements and market disclosures. This material is not intended to be relied upon as advice to investors or potential investors. Non-IFRS information ● Other than as indicated, the financial information contained in this document is d
Mayne Pharma Group Ltd. on 6ix
In the deck
Story so far
Earlier from Mayne Pharma
- 2019 Full Year Results Media Release
- 2019 Half Year Investor Presentation
- 2019 Half Year Media Release
- Half Year Accounts
- Tolsura (SUBA-itraconazole) capsule now launched in the US
Later from Mayne Pharma
- MYX signs license agreement for novel oral contraceptive
- E4/DRSP contraceptive presented at EU gynecology conference
- 2019 AGM CEOs Speech
- 2020 Half Year Media Release
- 2020 Half Year Investor Presentation
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma